• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Allogeneic hematopoietic stem-cell engraftment and graft failure.

作者信息

Woolfrey A, Anasetti C

机构信息

Fred Hutchinson Cancer Research Center, Seattle, WA 98104, USA.

出版信息

Pediatr Transplant. 1999;3 Suppl 1:35-40. doi: 10.1034/j.1399-3046.1999.00068.x.

DOI:10.1034/j.1399-3046.1999.00068.x
PMID:10587969
Abstract

Two immunologically mediated reactions, the graft-versus-host (GvH) and host-versus-graft (HvG) responses, form primary and opposing barriers to successful transplantation of allogeneic hematopoietic stem-cells (HSC). The HvG barrier is set by the strength of the allogeneic immune response, which is determined by antigenic stimulation provided by donor cells, owing to differences in histocompatibility antigens, and the capacity of host immune cells to generate a response. Risk of graft failure must be viewed as the interplay of multiple factors, including degree of human leukocyte antigen and minor histocompatibility antigen disparity, capacity of host immune response, and the capacity of donor hematopoietic and immunologic cells for overcoming residual host immunity.

摘要

相似文献

1
Allogeneic hematopoietic stem-cell engraftment and graft failure.
Pediatr Transplant. 1999;3 Suppl 1:35-40. doi: 10.1034/j.1399-3046.1999.00068.x.
2
[Allogeneic hematopoietic stem-cell transplantation for hematological malignancies].[异基因造血干细胞移植治疗血液系统恶性肿瘤]
Bull Cancer. 2001 Sep;88(9):908-26.
3
Hematopoietic engraftment and graft failure after bone marrow transplantation.骨髓移植后的造血植入与移植失败
Am J Pediatr Hematol Oncol. 1993 Feb;15(1):3-17. doi: 10.1097/00043426-199302000-00002.
4
Graft rejection after unrelated donor hematopoietic stem cell transplantation for thalassemia is associated with nonpermissive HLA-DPB1 disparity in host-versus-graft direction.地中海贫血患者接受非亲缘供者造血干细胞移植后的移植物排斥反应与宿主对移植物方向上不匹配的HLA-DPB1差异有关。
Blood. 2006 Apr 1;107(7):2984-92. doi: 10.1182/blood-2005-08-3374. Epub 2005 Nov 29.
5
Allogeneic peripheral blood stem cell transplantation from related donors mismatched at 2 HLA loci in the host-versus-graft direction.来自相关供者的异基因外周血干细胞移植,在宿主对移植物方向上有2个HLA位点不匹配。
Tohoku J Exp Med. 2008 Feb;214(2):159-63. doi: 10.1620/tjem.214.159.
6
Engraftment of allogeneic hematopoietic stem cells requires both inhibition of host-versus-graft responses and 'space' for homeostatic expansion.异体造血干细胞的植入既需要抑制宿主对移植物的反应,也需要有空间进行稳态扩增。
Transplantation. 2005 Jun 15;79(11):1484-91. doi: 10.1097/01.tp.0000159027.81569.4a.
7
Current and future approaches to treat graft failure after allogeneic hematopoietic stem cell transplantation.同种异体造血干细胞移植后移植物失败的当前和未来治疗方法。
Expert Opin Pharmacother. 2014 Jan;15(1):23-36. doi: 10.1517/14656566.2014.852537. Epub 2013 Oct 25.
8
Graft failure after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后的移植物失败
Transfus Apher Sci. 2018 Apr;57(2):163-167. doi: 10.1016/j.transci.2018.04.014. Epub 2018 Apr 18.
9
Transplantation of purified hematopoietic stem cells: requirements for overcoming the barriers of allogeneic engraftment.纯化造血干细胞的移植:克服异基因植入障碍的要求。
Biol Blood Marrow Transplant. 1996 Feb;2(1):3-14.
10
Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.基因和临床因素均能预测异基因造血干细胞移植后移植物抗宿主病的发生。
Transplantation. 2001 Aug 27;72(4):699-706. doi: 10.1097/00007890-200108270-00024.

引用本文的文献

1
Rescue treatment with eltrombopag in refractory cytopenias after allogeneic stem cell transplantation.艾曲泊帕对异基因干细胞移植后难治性血细胞减少症的挽救治疗。
Ther Adv Hematol. 2020 Oct 20;11:2040620720961910. doi: 10.1177/2040620720961910. eCollection 2020.
2
Successful treatment of secondary poor graft function post allogeneic hematopoietic stem cell transplantation with eltrombopag.艾曲波帕治疗异基因造血干细胞移植后继发性移植物功能不良的疗效观察。
J Hematol Oncol. 2018 Aug 16;11(1):103. doi: 10.1186/s13045-018-0649-6.
3
Uric acid as a novel biomarker for bone-marrow function and incipient hematopoietic reconstitution after aplasia in patients with hematologic malignancies.
尿酸作为血液系统恶性肿瘤患者再生障碍后骨髓功能及早期造血重建的新型生物标志物。
J Cancer Res Clin Oncol. 2017 May;143(5):759-771. doi: 10.1007/s00432-017-2348-z. Epub 2017 Feb 16.
4
Poor graft function can be durably and safely improved by CD34+-selected stem cell boosts after allogeneic unrelated matched or mismatched hematopoietic cell transplantation.在异基因非亲缘匹配或不匹配造血细胞移植后,通过CD34+选择的干细胞增强可持久且安全地改善移植功能不佳的情况。
J Cancer Res Clin Oncol. 2015 Dec;141(12):2241-51. doi: 10.1007/s00432-015-2027-x. Epub 2015 Aug 14.
5
Zebrafish model for allogeneic hematopoietic cell transplantation not requiring preconditioning.用于异基因造血细胞移植且无需预处理的斑马鱼模型。
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4327-32. doi: 10.1073/pnas.1219847110. Epub 2013 Feb 19.
6
Lack of antidonor alloantibody does not indicate lack of immune sensitization: studies of graft loss in a haploidentical hematopoietic cell transplantation swine model.缺乏抗供体同种异体抗体并不表明缺乏免疫致敏:在半相合造血细胞移植猪模型中研究移植物丢失。
Biol Blood Marrow Transplant. 2012 Nov;18(11):1629-37. doi: 10.1016/j.bbmt.2012.08.004. Epub 2012 Aug 11.